ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 100 filers reported holding ENDOCYTE INC in Q3 2013. The put-call ratio across all filers is 15.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $519,000 | -41.8% | 29,231 | -54.7% | 0.00% | -50.0% |
| Q2 2018 | $891,000 | +1436.2% | 64,588 | +375.7% | 0.01% | – |
| Q4 2017 | $58,000 | +141.7% | 13,578 | -19.8% | 0.00% | – |
| Q3 2017 | $24,000 | 0.0% | 16,920 | +7.0% | 0.00% | – |
| Q2 2017 | $24,000 | +380.0% | 15,820 | +890.6% | 0.00% | – |
| Q1 2016 | $5,000 | -92.9% | 1,597 | -88.1% | 0.00% | -100.0% |
| Q2 2015 | $70,000 | -68.3% | 13,427 | -61.8% | 0.00% | -66.7% |
| Q4 2014 | $221,000 | -44.5% | 35,138 | -46.3% | 0.00% | -50.0% |
| Q3 2014 | $398,000 | +107.3% | 65,487 | +355.1% | 0.01% | +50.0% |
| Q3 2013 | $192,000 | +700.0% | 14,389 | +692.8% | 0.00% | +300.0% |
| Q2 2013 | $24,000 | – | 1,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,211,302 | $74,793,000 | 19.97% |
| VHCP Management III, LLC | 600,000 | $10,656,000 | 8.05% |
| RA Capital Management | 6,196,143 | $110,043,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 1,606,100 | $28,524,000 | 4.44% |
| Avoro Capital Advisors LLC | 5,301,718 | $94,159,000 | 4.32% |
| Ghost Tree Capital, LLC | 1,100,000 | $19,536,000 | 4.15% |
| Crosspoint Capital Strategies, LLC | 104,573 | $1,857,000 | 3.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,514,084 | $62,410,000 | 2.24% |
| NEXTHERA CAPITAL LP | 654,532 | $11,624,000 | 2.23% |
| EMORY UNIVERSITY | 148,628 | $2,640,000 | 1.73% |